QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
Log in
NASDAQ:MLAB

Mesa Laboratories Stock Forecast, Price & News

$276.01
-0.93 (-0.34 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$274.06
Now: $276.01
$278.75
50-Day Range
$274.67
MA: $285.90
$297.01
52-Week Range
$181.90
Now: $276.01
$307.97
Volume22,087 shs
Average Volume23,666 shs
Market Capitalization$1.42 billion
P/E RatioN/A
Dividend Yield0.23%
Beta0.39
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instruments segment offers data loggers used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air sampling; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. The company's Biopharmaceutical Development segment develops, manufactures, and commercializes automated solutions for protein analysis, which include analysis equipment, CDs, kits, and buffers; and peptide synthesizers to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. Its Continuous Monitoring segment offers systems, which are used to monitor temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was founded in 1982 and is headquartered in Lakewood, Colorado.
Mesa Laboratories logo

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Current SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000
Employees460
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$117.69 million
Cash Flow$9.31 per share
Book Value$50.34 per share

Profitability

Net Income$1.35 million

Miscellaneous

Market Cap$1.42 billion
Next Earnings Date6/7/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.51 out of 5 stars

Medical Sector

420th out of 1,957 stocks

Process Control Instruments Industry

9th out of 25 stocks

Analyst Opinion: 1.0Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$276.01
-0.93 (-0.34 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

Is Mesa Laboratories a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Mesa Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MLAB, but not buy additional shares or sell existing shares.
View analyst ratings for Mesa Laboratories
or view top-rated stocks.

What stocks does MarketBeat like better than Mesa Laboratories?

Wall Street analysts have given Mesa Laboratories a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mesa Laboratories wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release its next quarterly earnings announcement on Monday, June 7th 2021.
View our earnings forecast for Mesa Laboratories
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings data on Thursday, August, 6th. The medical instruments supplier reported $0.22 EPS for the quarter, missing the Zacks' consensus estimate of $0.76 by $0.54. The medical instruments supplier earned $29.94 million during the quarter, compared to analyst estimates of $31.70 million. Mesa Laboratories had a positive trailing twelve-month return on equity of 6.39% and a negative net margin of 2.04%.
View Mesa Laboratories' earnings history
.

How has Mesa Laboratories' stock price been impacted by Coronavirus (COVID-19)?

Mesa Laboratories' stock was trading at $230.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MLAB stock has increased by 19.5% and is now trading at $276.01.
View which stocks have been most impacted by COVID-19
.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, January 5th. Shareholders of record on Friday, February 26th will be paid a dividend of $0.16 per share on Monday, March 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Thursday, February 25th.
View Mesa Laboratories' dividend history
.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.23%. Mesa Laboratories does not yet have a strock track record of dividend growth. The dividend payout ratio of Mesa Laboratories is 15.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 10.29% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.
View Mesa Laboratories' dividend history.

What price target have analysts set for MLAB?

2 equities research analysts have issued 1-year price objectives for Mesa Laboratories' stock. Their forecasts range from $260.00 to $287.00. On average, they anticipate Mesa Laboratories' share price to reach $273.50 in the next year. This suggests that the stock has a possible downside of 0.9%.
View analysts' price targets for Mesa Laboratories
or view top-rated stocks among Wall Street analysts.

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the following people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 53, Pay $1.19M)
  • Mr. John V. Sakys, CFO, Chief Accounting Officer & Treasurer (Age 52, Pay $596.4k)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 56, Pay $491.16k)
  • Mr. Brian David Archbold, Sr. VP of Continuous Improvement (Age 56, Pay $423.68k)
  • Mr. Robert Bradley, Sr. Director of Operations
  • Ms. Elizabeth Karpinski Vonne, VP of Legal, Gen. Counsel & Sec.
  • Ms. Gina Hinman Trulli, VP of HR
  • Mr. Bryan T. Leo, Sr. VP of Operations
  • Mr. Garrett Krushefski, Sr. VP of Operations

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories CEO Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among Mesa Laboratories' employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.16%), Conestoga Capital Advisors LLC (9.86%), Royce & Associates LP (5.99%), Price T Rowe Associates Inc. MD (5.09%), Artisan Partners Limited Partnership (2.55%) and Schroder Investment Management Group (2.12%). Company insiders that own Mesa Laboratories stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Robert V Dwyer.
View institutional ownership trends for Mesa Laboratories
.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Renaissance Technologies LLC, Dimensional Fund Advisors LP, Aviva PLC, Oak Ridge Investments LLC, Royce & Associates LP, Northern Trust Corp, and Candriam Luxembourg S.C.A.. Company insiders that have sold Mesa Laboratories company stock in the last year include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, and John Sakys.
View insider buying and selling activity for Mesa Laboratories
or view top insider-selling stocks.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Glenmede Trust Co. NA, Schroder Investment Management Group, Wells Fargo & Company MN, Morgan Stanley, Conestoga Capital Advisors LLC, Eaton Vance Management, and DF Dent & Co. Inc..
View insider buying and selling activity for Mesa Laboratories
or or view top insider-buying stocks.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $276.01.

How much money does Mesa Laboratories make?

Mesa Laboratories has a market capitalization of $1.42 billion and generates $117.69 million in revenue each year. The medical instruments supplier earns $1.35 million in net income (profit) each year or $4.21 on an earnings per share basis.

How many employees does Mesa Laboratories have?

Mesa Laboratories employs 460 workers across the globe.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is www.mesalabs.com.

Where are Mesa Laboratories' headquarters?

Mesa Laboratories is headquartered at 12100 W 6TH AVE, LAKEWOOD CO, 80228.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.